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Abstract: The objective of this study was to assess speciﬁ  c areas of life in which obesity affects 
individuals with type 2 diabetes mellitus (T2DM), and changes that obese persons with T2DM 
experience with weight loss of varying degrees. Thirty in-depth interviews were conducted in 
persons identiﬁ  ed as: age 40 years, diagnosed with T2DM for 2 years, on oral antihypergly-
cemic medications 3 months, BMI 30–35 kg/m2, having attempted to lose weight in the last 
2 years. Participants (60% female, mean age 53 years, 53% Caucasian, mean BMI 32.2 kg/m2) 
agreed that 5% weight loss, while not reﬂ  ective of an ultimate goal, would be meaningful and 
important; beneﬁ  ts were expected to accrue in physical functioning, self-conﬁ  dence, blood 
glucose levels, and motivation to keep losing weight. Participants reported the greatest effect 
of weight loss on energy, physical activity, mobility, pain, and clothes/appearance. Participants 
reported weight affecting mood, with feelings of depression and frustration most commonly 
described. This research indicates that weight loss is likely to affect health-related quality of life 
in obese individuals with T2DM. Given the purported weight loss beneﬁ  ts of many emerging 
diabetic medications, it will be important to include measures of weight-related quality of life 
in future clinical trials of these agents.
Keywords: health-related quality of life, obesity, type 2 diabetes, weight loss, patient- reported 
outcomes
Introduction
Patient-reported outcomes (PROs) describe health and treatment experience from the 
patient perspective. Over the past 15 years the pharmaceutical industry has increas-
ingly included PRO measured as primary efﬁ  cacy or key secondary endpoints in drug 
therapy clinical trials (Leidy and Vernon 2008). The goal is to provide not only clinical 
information about new drug therapy, but also information about the effect of the drug 
therapy on aspects of life that are valued by patients (ie, health-related quality of life). 
Armed with this knowledge, a clinician is better prepared to effectively communicate 
to patients both the advantages, and disadvantages, of options for drug therapy, and 
negotiate the treatment option that will most beneﬁ  t the patient.
Type 2 diabetes mellitus (T2DM) is a disorder characterized by a decreased abil-
ity of the body to use insulin, leading to the inability to regulate blood sugar. If left 
untreated, poor glycemic control can lead to increased morbidity and mortality (King 
et al 1999; Cox et al 2002; ADA 2008). PRO endpoints are particularly relevant in 
chronic diseases such as diabetes in which there are multiple options for treatment 
with similar clinical efﬁ  cacy but tradeoffs in terms of symptom reduction, side effects, 
convenience and ﬂ  exibility, and route of administration (Hayes et al 2006). Because 
the aim of antihyperglycemic medications is to control blood sugar, the primary 
endpoint of most clinical trials evaluating these agents is hemoglobin A1c (HbA1c). 
PRO secondary endpoints have the potential for supplementing this clinical labora-
tory value with patient-perceived changes in, for example, physical, emotional, and Diabetes, Metabolic Syndrome and Obesity 2008:1 14
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social functioning, as well as providing information about 
treatment satisfaction and/or preference, thus differentiating 
therapies.
New antihyperglycemic medications such as incretin 
mimetics have demonstrated the ability to produce not only 
reductions in HbA1c but also average reductions in weight 
of 5% to 10% (Buse et al 2004; Harder et al 2004; Kim et al 
2007). Previous work has revealed that as many as 80% of 
individuals with T2DM are overweight or obese [Body Mass 
Index (BMI) 25.0–29.9 and 30, respectively] (Ford et al 
2005; Ogden et al 2006), and as such weight loss represents 
not only an additional clinical beneﬁ  t, but also may be a 
measurable beneﬁ  t from the patient perspective.
There are several reliable and validated obesity-speciﬁ  c 
or generic instruments available that have been used as 
patient-reported outcomes measures in clinical trials for 
obesity medications. However, these measures, for example, 
the Impact of Weight on Quality of Life Lite (IWQOL-Lite), 
tend be sensitive to large amounts of weight loss as would 
more likely be seen with surgical techniques developed 
speciﬁ  cally for weight loss in the morbidly obese (Kolotkin 
et al 2002; Kolotkin et al 2003). More importantly, to our 
knowledge, none of these measures have been developed 
speciﬁ  cally in populations of patients with T2DM with 
moderate obesity and, therefore, may not include all domains 
of importance to people with T2DM who are also obese and 
may experience weight loss of 5% to 10% of their body 
weight. Therefore, the development of a measure of the 
effect of drug therapy that results in a 5% to 10% weight 
loss in addition to improved glycemic control in people with 
T2DM may be warranted.
Qualitative research methods form the basis for new PRO 
measures or adapting of existing measures (Leidy and Vernon 
2008) and the open, exploratory nature of the methodology 
is well suited to understanding the experiences of consumers 
and health professionals (Pope and Maze 1995). Accordingly, 
the objectives of this research were to qualitatively:
1)  Identify the areas of life in which weight most affects 
people with T2DM and moderate obesity.
2)  Identify the areas of life affected by weight loss, which 
these people expect to experience, or have experienced 
changes in, to varying degrees.
3)  Identify those changes that are the most important and 
relevant to individuals with T2DM who are moderately 
obese.
From the results of this work we will seek to develop 
expected relationships among concepts that will guide 
selection of appropriate patient-reported outcomes measure 
selection for the evaluation of diabetes drug therapies that 
result in weight loss.
Methods
Study design
This study was a qualitative study using in-depth interviews. 
An in-depth interview is a face to face conversation between 
interviewer and interviewee with the purpose of exploring 
issues or topics in detail. Interview questions are not preset 
but are shaped by a deﬁ  ned set of topics. In-depth interviews, 
as opposed to focus groups in which 6 to 10 people with a 
common attribute (eg, T2DM) are brought together to discuss 
their experiences with a skilled moderator, are particularly 
well-suited for topics that are particularly personal or sensi-
tive (eg, sexual relations) (Leidy and Vernon 2008).
Study participants
Interviews were conducted in the US during the month of 
May 2007 in Raleigh (NC) and Philadelphia (PA) in an 
attempt to broaden participant and geographical diversity. 
Eligible participants were required to meet the following 
self-reported criteria:
•  Aged 40 years or older;
•  Diagnosed with T2DM for at least 2 years;
•  Managing their diabetes with medication(s) for at least 
the past 3 months;
•  Have a body mass index (BMI) between 30 and 35; and
•  Attempted to lose weight in the last 2 years.
Individuals were excluded from the study if they reported 
a pregnancy in the last 2 years, a surgical procedure for 
weight loss, signiﬁ  cant weight loss due to a major medical 
condition, or the use of insulin. For each round of interviews, 
efforts were made to recruit participants diverse in age, 
gender, race, and educational background.
Procedures
As part of the study, and preceding any contact with patients, 
the project was reviewed by an Institutional Review Board 
(IRB) committee. The services of a qualitative research 
ﬁ  rm, with access to a database of individuals interested in 
participating in qualitative research were utilized. Addition-
ally, these ﬁ  rms advertise on their website to increase the 
pool of potential participants. Trained recruiters at each 
respective research facility called potential participants in 
their database in an effort to ﬁ  nd individuals who were both 
eligible and interested in participating in the interviews. To 
facilitate sample selection, each qualitative research ﬁ  rm used Diabetes, Metabolic Syndrome and Obesity 2008:1 15
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a screening form. Recruitment continued until the desired 
number of participants had been reached.
Prior to commencing each interview, informed consent 
was obtained from each participant. All interviews were 
conducted by 3 experienced qualitative interviewers accord-
ing to a pre-established interview guide developed by the 
authors. The interviews were conducted face-to-face at 
the qualitative research ﬁ  rms’ facilities. Two interviewers 
(SF, LZ) were present for each interview; one person led the 
interview while the other person took notes and interjected 
comments and/or questions as appropriate. The interviews 
were audio-taped in order to create transcripts and on average 
lasted for 60 minutes. None of the interviews were observed 
by a third party. As compensation for their time and travel, 
each participant received a cash reimbursement.
To start the interview, participants were asked a series of 
general, open-ended questions about their experiences with 
diabetes and weight and the relationship between the two. The 
interview continued with questions to ascertain how weight 
affects various areas of functioning (eg, physical functioning 
and mobility, work and role functioning, social functioning, 
and emotional functioning) independent of diabetes or other 
comorbidities.
At the end of the interview, participants were asked to 
review the Impact of Weight on Quality of Life-Lite Question-
naire (IWQOL-Lite). The IWQOL-Lite is an obesity-speciﬁ  c, 
31-item, self-report instrument designed to assess individuals’ 
perceived effects of their weight on their quality of life 
that has been used in clinical trials evaluating medications 
indicated for obesity (Lustig et al 2006; Di Francesco et al 
2007). The IWQOL-Lite consists of 5 subscales (physical 
function, self-esteem, sexual life, public distress, and work). 
Respondents are asked to respond to IWQOL-Lite items by 
indicating, on a 5-point scale (1 = never true, 5 = always 
true), the extent to which the item describes themselves in 
the past week (Kolotkin et al 2001). For the purposes of this 
study, participants were not administered the IWQOL-Lite, 
but were asked to indicate which of the items were relevant 
to their experience with diabetes and/or being obese.
Analysis
Standard qualitative data collection and analysis methods, 
including researcher neutrality and systematic process, were 
used to analyze the qualitative data. Data were systematically 
collected in the form of ﬁ  eld notes and audiotapes for each 
individual subject interview. Following the conclusion of 
the interviews all audiotapes were transcribed and prepared 
for analysis. A thematic analysis approach was then used to 
evaluate and summarize the information contained within the 
interview transcripts. Thematic analysis focuses on identiﬁ  able 
themes and patterns of living and/or behavior (Grbich 2007). 
Using this approach, key points were identiﬁ  ed within each 
interview and then compared across the results of the other 
interviews by 2 researchers (SF, LZ) to generate themes and elu-
cidate patterns in the way subjects described the effect of their 
weight on their functioning. A frequency distribution (relevant? 
Yes = 1) was calculated for the 31 IWQOL-Lite items.
Results
Participant characteristics
Twelve men and 18 women between the ages of 40 and 
76 years (mean 53.3 years) with a mean BMI of 32.2 kg/m² 
participated in the study. Across interviews, the sample was 
predominantly white, female, and educated (at least some 
college). Characteristics of the participants are presented in 
Table 1. All participants reported currently using 1 or more 
Table 1 Participant characteristics
Characteristic n %
Age
 40–49  years 10 33
 50–59  years 16 53
 60  + years 41 4
Gender
 Female 18 60
 Male 12 40
Education
  High school or equivalent 4 13
  Some college but no degree 9 30
 Associate degree 2 7
 College  degree 11 37
 Graduate  degree 4 13
Race/Ethnicity
 White 16 53
 Black 14 47
Time since diabetes diagnosis (years)
  More than years and less than 6 years 15 50
  Between 6 and 10 years 12 40
  More than 10 years 3 10
Body mass index (kg/m2)
 30 4 13
 31 6 20
 32 6 20
 33 6 20
 34 6 20
 35 2 7Diabetes, Metabolic Syndrome and Obesity 2008:1 16
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medications for the treatment of their diabetes. Table 2 
provides the frequency of diabetes medication use.
General discussion of diabetes 
and weight
While several participants indicated that they did not experi-
ence symptoms of diabetes prior to diagnosis, most experi-
enced symptoms typically associated with diabetes such as 
feeling thirsty, frequent urination, fatigue, and blurry vision. 
Many reported a family history of diabetes. When asked to 
describe the hardest thing about living with diabetes, the 
vast majority of participants talked about the difﬁ  culty of 
managing diet, particularly avoiding foods they enjoyed. For 
example, one participant responded:
…I watch my carbs more than I do my sugars because 
everybody tells me, “Well you can’t have sugar.” And 
I look at them like, huh? Forget that, that’s not what all the 
books say…I eat basically what I want. But I just don’t eat 
a whole lot of it….if you watch the scale every day you 
get [disheartened].
(Female, 55 years, BMI 32 kg/m²)
In a general discussion of the hardest things about 
being overweight, many participants expressed that weight 
negatively affected their energy levels, stamina, breathing, 
flexibility, comfort levels, and overall physical ability. 
Some participants indicated that being overweight lowered 
self-esteem while others reported that the only negative 
consequence to being overweight was the difﬁ  culty they 
experienced ﬁ  nding clothes that ﬁ  t, were comfortable, and 
that looked nice.
Relationship between diabetes 
and weight
Each interview ﬂ  owed into a discussion of the relationship 
between diabetes and weight. Approximately half of the 
participants reported that some aspect of their diabetes 
either made them gain weight or made it harder for them 
to lose weight. Another common theme was that diabetes 
“caused an increase in appetite” and increased “cravings 
for certain foods” which led to an increase in weight. A few 
participants went on to note that if they lost enough weight 
they may be able to control their diabetes without the use 
of medications.
After discussing the relationship between diabetes and 
weight, moderators asked participants which was more 
important to them, controlling blood sugar or weight. Without 
exception all participants expressed the importance of both 
blood sugar control and a 5% to 10% weight loss. Many 
participants indicated that controlling blood sugar was a 
priority because of the medical complications associated with 
diabetes. As one participant commented,
Controlling the blood sugar [is most important] deﬁ  nitely. 
I mean that’s what’s gonna kill me, you know what I mean? 
If that shoots out of control, that’s what’s gonna put me in 
the hospital and cause all the other side effects of diabetes. 
Weight is important to me, but it’s not gonna kill me, at 
least not right away.
(Male, 51 years, BMI 31 kg/m²)
In contrast, about one third of participants indicated that 
moderate weight loss would be more important to them than 
controlling their blood sugar, reasoning blood sugar levels 
would be controlled as a result of the weight loss, and they 
favored the overall beneﬁ  t they would receive.
I’d probably love to lose 10 to 15 pounds. I think I’d look 
better in my clothes, and I’d have a better attitude about 
myself…I think that would help me maintain what I have 
to do to keep my sugars at a lower level.
(Female, 53 years, BMI 31 kg/m²)
Smallest signiﬁ  cant weight loss
When asked to think about the smallest amount of weight 
loss that would be signiﬁ  cant, some participants volunteered 
an amount equal to approximately 5% of their total body 
weight. Other participants initially gave an amount more 
substantial than 5% of their body weight. When probed 
whether 5% was signiﬁ  cant, however, nearly all agreed 
that a 5% to 10% weight loss of 5% would be important, 
and that beneﬁ  ts in areas such as physical functioning, 
Table 2 Frequency of medication use among participants
Brand name of drug Generic name of drug Number 
of users
Actos pioglitazone 2
Actoplus met metformin + pioglitazone 1
Amaryl glimepiride 3





Glucotrol XL xl glipizide (long-acting) 2
Glucovance metformin + glipizide 2
Januvia sitagliptin 2Diabetes, Metabolic Syndrome and Obesity 2008:1 17
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self-conﬁ  dence, blood sugar levels, and how clothes ﬁ  t 
would be seen. In addition, several participants noted that 
a 5% weight loss would provide motivation to keep losing 
weight, a point that was repeated by participants throughout 
the interviews.
General effect of weight on life
Physical functioning and mobility
Of all areas of life, participants reported that weight had 
the greatest effect on physical functioning and mobility. 
Almost all participants said that weight loss directly affected 
(or would affect) their level of energy, their stamina, and 
their levels of fatigue.
I’m limited, yes. Jogging, which I used to do, was able to 
do years ago, but cannot do anymore and I know has noth-
ing to do with my age, because I have a sister that’s 42 and 
she jogs everyday.
(Female, 40 years, BMI 31 kg/m²)
Just little things like running up and down the steps. I always 
used to be able to run up and down stairs or skip. I have 
a 16-year-old daughter, and she and I used to always go 
running together cause she’s on a track team. I can’t do 
it anymore.
(Female, 40 years, BMI 34 kg/m²)
With extra weight, participants said they tired more eas-
ily from physical activity and felt more sluggish in general. 
Participants repeatedly expressed that they felt their energy 
levels and stamina had improved (would improve) with a 
5% to 10% weight loss.
The extra weight, it just makes me feel more sluggish, 
I mean there are some nights I just come home, and I just 
sit there, and I don’t move. And I know I should go do 
something, but I just don’t have the energy.
(Male, 57 years, BMI 30 kg/m²)
I think there are 40 buildings on our base and my building 
is number 6. So if I park my car outside the base, walking 
into six buildings has become an issue. Before I walked to 
all of the buildings, 20, and did not feel a difference, but 
lately I have been feeling a difference that I have to stop a 
little bit and catch my breath or walk at a slower pace.
(Female, 40 years, BMI 34 kg/m²)
Mobility
About one third of participants said that mobility was nega-
tively affected by weight gain. Day-to-day activities such as 
walking and climbing stairs were (or would be) easier with 
weight loss. In addition, breathing difﬁ  culties or shortness 
of breath during physical activities was reported.
I can’t even walk up a ﬂ  ight of steps like I used to. It’s just 
draining. Just your whole overall, the way you look, and the 
way you feel. I can really see how it really, it drains you.
(Female, 40 years, BMI 34 kg/m²)
Being able to breathe. You know, being able to have the 
physical abilities that you become accustomed to. I just 
tire easily. Probably a whole lot more depressed being 
overweight. Well, you know, I think sometimes being heavy 
just takes away your motivation to get out and exercise 
because, you know, like I said, you don’t breathe as good, 
you don’t move as good.
(Female, 59 years, BMI 32 kg/m²)
Some participants noted that their weight did not hold 
them back from doing physical activities, but that a 5% to 
10% weight loss would certainly make those activities easier. 
Speciﬁ  cally, participants said they had (or would have) an 
easier time getting up and bending over with a 5% to 10% 
weight loss. Several participants explained that speciﬁ  cally 
the weight they carried around their midsection was uncom-
fortable and inhibited mobility.
It’s the extra weight, and I hold mine in the middle, so 
that’s worse. But not being able to do things like, if a bus 
was coming, I can’t even run for the bus without being, you 
know, out of breath or feeling like I’m about to die.
(Female, 40 years, BMI 34 kg/m2)
Probably ‘cause of the middle. It’s because most of my 
weight is all in my middle. Um, just can’t bend as much. 
And it also could be age or because of the weight, if I get 
down and get somethin’ out of the lower cabinet, I can’t 
get back up.
(Female, 52 years, BMI 30 kg/m2)
Role limitations
The majority of participants said that engaging in physical 
activities such as playing with children, yard work, walking, 
running, and other sports were not only easier with weight 
loss but that they were more motivated to participate in these 
types of activities with a 5% to 10% weight loss.
Well, I’ve eliminated like, cutting the grass. We pay 
somebody to do it. I just don’t think that I can go out with 
the mower, and walk behind the mower for an hour and a 
half to cut the grass. It’s just, maybe if I lost the weight, 
I’d have enough stamina to take on some of the chores that 
I’ve given up, and now I pay someone to do it.
(Male, 57 years, BMI 30 kg/m²)
I watch my neighbor; my neighbor’s daughter’s married 
and they live with them, so they can save some money to 
get a house. The people who are our age are running around Diabetes, Metabolic Syndrome and Obesity 2008:1 18
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with the kids all the time. And it’s great for them, because 
they’re watchin’ the kid grow up but I don’t know if I’d be 
able to keep up with them.
(Male, 57 years, BMI 30 kg/m²)
Pain
Pain was reported to be affected by weight. About one quar-
ter of participants said they experienced pain in their back, 
knees, and/or feet that they said was (or would be) alleviated 
with a 5% to 10% weight loss. A few participants expressed 
feeling “heavy on their feet” because of extra weight, and 
one participant stated that his weight exacerbated the arthritis 
in his knee and hip.
I’d feel better, you know. I think my feet would feel bet-
ter too. I have really bad wheels. Bad femoral structure; 
I inherited that. And I know when I lose some weight, my 
feet are always better. ‘Cause they always hurt. My feet are 
always in pain. Somethin’ called Charcot foot, it’s hard to 
explain, but every time I gain weight, I can actually feel it 
more in my knees and in my feet.
(Female, 52 years, BMI 30 kg/m²)
Okay, like my knees, my knees, like I think from having 
all this weight has put, you know. Okay I stopped walking 
up the ole steps because it’s like, it was just, you know, 
painful, I guess.
(Female, 57 years, BMI 30 kg/m²)
Clothes and appearance
For more than half of participants, weight affected the 
comfort, ﬁ  t, and appearance of their clothes. Many of these 
participants expressed frustration over the difﬁ  culty in ﬁ  nd-
ing clothes that ﬁ  t comfortably and looked good, and they 
were excited by the thought of being able to wear smaller 
sizes and different designs if they lost a moderate amount 
of weight.
I’d like to ﬁ  t into all those clothes. You know, I ﬁ  nd myself 
wearing Hawaiian shirts, shirts that are out, where I never 
wore a shirt like that before, and be, by wearing it out, 
it hides some of the extra weight. I have to, I just like to 
feel more comfortable in what I have instead of looking 
for something different that’s gonna disguise some of the 
weight. See all those things will lead you to more active 
and to feel better about your self-esteem too, so, and then 
it makes you want to do other things.
(Male, 46 years, BMI 33 kg/m²)
She always tries to tell me to cover this up and wear this 
and wear that, but what you basically need to do is lose 
your stomach…….but she’s 13.
(Female, 40 years, BMI 31 kg/m²)
And I’m afraid to get rid of them fat clothes. I keep them. 
And I also have some jeans that I haven’t been able to get 
to in years, but I won’t get rid of them. It’s like I have to 
have that range. Is that a psychological thing? Maybe, uh, 
I don’t know. I do have a range of stuff in the closet. So 
I never know, am I gonna blow up again or am I gonna get 
thinner, you know. I just, I have to always have something 
that I can wear, but I don’t know if it’s a fear factor or 
what, but yes.
(Female, 52 years, BMI 30 kg/m²)
No effect
Only a few participants reported that a 5% weight loss had 
(or would have) no effect on physical functioning and mobil-
ity. Some had either been heavy all of their lives or had 
always struggled with their weight. Thus, they were content 
with and not physically limited by their current weight and 
did not see a need for improvement. The others thought 5% 
weight loss might motivate them to lose more weight but 
would not result in a noticeable change in physical function-
ing or mobility.
Work and role functioning
Most participants described their jobs as “sedentary” and 
reported that weight had no effect on their work functioning.
I don’t think that that diabetes or my weight really affects 
me adversely in that sense. Am I as sharp as I used to be? 
Probably not. Do I enjoy the workload? No. Am I so adversely 
affected that I can’t do the work? I don’t think so.
(Male, 46 years, BMI 31 kg/m²)
However, about one third of participants whose jobs 
involved a physical component said that weight did affect 
those speciﬁ  c physical activities. One participant, who works 
as a ﬁ  reﬁ  ghter, said that with weight loss it was easier for 
him to carry his equipment. Another participant said that 
being overweight made it harder for him to climb in and out 
of his work truck. Other participants said that with weight 
loss, they were more likely to take the stairs at work or walk 
from one building to the next.
Some participants noted that extra weight likely made 
them feel more sluggish and less alert. In addition, a few 
participants said that their weight would affect whether or 
not they would apply for a new job. One participant said that 
if she needed to go on job interviews in the future, she would 
make an effort to lose weight ﬁ  rst.
Well, when I was working, um, that affects you a lot. 
Now, you see, it’s one thing when you’re home and you’re 
with your family and your husband and you can be casual Diabetes, Metabolic Syndrome and Obesity 2008:1 19
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and stuff. At work, you know. You need to groom yourself 
well. You need to be, you know, presentable, you need to be 
professional. And sometimes that’s taken as being sloppy 
and so on. It really isn’t. It’s just things do not drape as well 
when you’re, when you lose weight. You feel much better 
and you present yourself better because you have more 
conﬁ  dence again. So it just, you know, ekes out I think.
(Female, 45 years, BMI 35 kg/m²)
Social functioning
Social activities
About half of participants said that their weight affected 
social activities. The majority of these participants were 
women who said they would be more likely to go out, in 
general, with a 5% to 10% weight loss. A few participants 
(men and women) said that non-physical activities (eg, going 
to the movies) were not affected but that social activities 
involving a physical aspect (eg, bowling, playing basketball) 
were affected by weight.
Yes, cause, at times I used to like to go out and socialize; if 
we go out to a nice little bar area of Philadelphia to different 
functions. I might dress in cute clothes and stuff. But at 
this point, it’s not about the clothing but different stuff that 
I really don’t feel comfortable. And I don’t feel comfortable 
in my clothing, you know, So I socially, you know, don’t get 
involved, I stay more at home and I’m more of a babysitter. 
Yes, I used to like go out, but I’m a very private person. But 
I do like to go out and socialize. But because of my weight 
issue and weight problem, I am very discouraged.
(Female, 40 years, BMI 31 kg/m²)
Social relationships
For the most part, discussions with participants on social 
relationships revealed that their relationships with friends and 
family members were not affected by their weight, but that 
with weight loss, participants are (or would be) more likely to 
go out and participate in social activities with those people.
You know, my friends are my friends regardless of my 
weight. They’ve known me all my life. They know my 
weight goes up and down, and, you know, they know it’s 
my problem, and they don’t have a problem with it.
(Male, 46 years, BMI 33 kg/m²)
However, about one quarter of participants reported some 
effect on social relationships.
Well, socially it’s been messing with me, cause all my 
friends tease me now. Cause I was so small, um, and just 
in general, like how I feel on days. I feel like I’m old. Like 
I really feel old. I feel older than 40.
(Female, 40 years, BMI 34 kg/m²)
Half of these participants thought that weight affected 
their intimate relationships, either existing sexual relation-
ships with a partner or their motivation to start a new intimate 
relationship with another person.
I just met a young lady and we’re gonna be goin’ out, and 
it’s gonna be a week from now, so I’m gonna get my gym 
membership. I’m gonna make sure I walk three times a 
week, no, you know, that, I guess you look better, you 
feel better, or at least you might think you look better, you 
know. It’s important.
(Male, 47 years, BMI 32 kg/m²)
One participant reported strained relationships with her 
sisters who were smaller than her and who put pressure on 
her to lose weight. Another participant said she was jeal-
ous of her “smaller” friends. Almost all of the participants 
who reported an effect on their social relationships were 
female.
Maybe in social settings, when my friend, who just looks 
absolutely perfect all the time, all the time. And you know, 
I love her and I’m glad she looks the way she does, but 
I think, wow, how come I can’t look this? Of course, she so 
little, but. It would be nice to look that cute, you know. She 
always has everything perfect about her. She’s just perfect. 
It depends on who I’m with I guess. It just depends.
(Female, 59 years, BMI 34 kg/m²)
Emotional functioning
About half of participants said that their self-esteem and/or 
self-conﬁ  dence had improved (or would improve) with 
weight loss. One participant said she gets discouraged when 
she looks at herself in the mirror, and another participant said 
she seldom looks at herself in the mirror because she does 
not like how she looks. A few participants said that they 
would be embarrassed to be seen in a swimming suit at the 
beach or the pool.
In photographs. Yes! Yes! There was a new baby born in 
the family, some 14 days old, and they took pictures. And 
they put them on the computer, and I’m like, ah God, I hate 
that, take them pictures off there will ya. The baby was 
cute, she was real pretty, but it’s like my God, um, am I 
embarrassed to be seen in? That’s a no. If I was that guy 
on TV that does the bed, the big guys a thousand pounds, 
you know, uh, no.
(Female, 52 years, BMI 30 kg/m²)
Additionally, some participants who would normally 
describe themselves as having an outgoing personality said 
that their increased weight made them feel more withdrawn 
and less assertive.Diabetes, Metabolic Syndrome and Obesity 2008:1 20
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Like, I’m the life of the party type person. And now I don’t 
really want to go out. It’s like I’ll go out every now and 
then, but it’s like pulling teeth. They have to drag me. I just 
have no interest. If I know it’s only going to be them there, 
I’m comfortable. Like I could go to their houses and that’s 
ﬁ  ne. But when there are other people around, especially new 
people I don’t know, I don’t want to be bothered.
(Female, 40 years, BMI 34 kg/m²)
Over half of participants reported that weight affected 
their mood. These participants reported feelings of depres-
sion, frustration, negativity, and intolerance which they 
attributed to their weight. In addition, a few participants said 
they felt fear or anxiety because of the effect of their weight 
on their health.
Because before I had this weight, I never like, I suffer from 
depression now. And I was never sad. I was, like I said, the 
life of the party. Jump up, I was very optimistic about life 
and things, and every day was like a, “Good morning,” you 
know. Now it’s like, “I can’t believe I have to live through 
another day being fat.
(Female, 40 years, BMI 34 kg/m²)
Yeah. I have to watch myself because my leg swells up. 
You know I’m worried about losing limbs and things like 
that, that I shouldn’t have to be worrying about it. That’s 
just a depressing thing.
(Female, 54 years, BMI 33 kg/m²)
Well, I do have a tendency to stay at home more, sit on the 
couch more, and stay in more. I don’t know if all that’s, 
you know, attributed to weight gain or just attitude. You 
know, maybe the next study they do on diabetes will be the 
depression. Maybe, maybe that does have something to do 
with it; I don’t know. But, I would think so.
(Female, 59 years, BMI 32 kg/m²)
Nearly one third of participants said that weight had no 
effect on their mood or self-conﬁ  dence. Most of these were 
participants who had always had weight issues and reported 
being happy with who they were.
At the conclusion of the interview, each participant 
reviewed the IWQOL-Lite and was asked to identify items 
that were relevant to them based on their weight and/or dia-
betes. The items endorsed as being relevant in each of the 
subscales are presented in Table 3.
Discussion
The overall goal of this qualitative study was to gain a deeper 
understanding of the effect of weight on individuals with 
T2DM and moderate obesity (30–35 BMI). Data were col-
lected from 30 participants with T2DM and moderate obesity 
through in-depth interviews conducted by professional 
interviewers. Although residing in either Raleigh, NC or 
Philadelphia, PA, the 30 participants were diverse in terms of 
their age, gender, ethnicity, education, duration of diabetes, 
and oral antihyperglycemic medications.
In a review of 100 studies pertaining to quality of life 
and diabetes, Rubin and Peyrot (1999) identiﬁ  ed themes 
regarding diabetes treatment. They were (1) quality of life 
increased with better glucose control but only if decreases 
were not accompanied by increased treatment burden and 
hypoglycemia; (2) quality of life in patients with diabetes 
could be improved with, among other things, changes in 
insulin delivery systems; and (3) quality of life decreased 
with intensiﬁ  cation of treatment.
These themes were consistent with the primary themes 
that emerged from 18 focus groups in a qualitative study 
designed to understand the perceptions of people with T2DM 
regarding their medications (Hayes et al 2006). Because 
many antihyperglycemic medications have similar clinical 
efﬁ  cacy in terms of glycemic control, treatment satisfaction 
and preference are typically based on patient perceptions of 
convenience and ﬂ  exibility or route of administration, not 
meaningful improvements in functioning.
With new antihyperglycemic medications that potentially 
result in a 5% to 10% weight loss, however, there is potential 
for a differentiator beyond convenience or route of admin-
istration. This potential will be determined by the extent to 
which people with T2DM perceive a 5% to 10% weight loss, 
in addition to improved glycemic control, as relevant.
The results of this study indicated that people with 
T2DM would value a 5% to 10% weight loss particularly as 
it applies to their physical functioning. Physical functioning 
was clearly the most affected by participants’ weight with 
lack of energy or fatigue, shortness of breath, pain, and 
immobility as the most prevalent symptoms. Participants 
conﬁ  rmed their comments in their review of the IWQOL-
Lite items. The majority of items considered relevant by 
50% or more participants came from the IWQOL-Lite 
physical functioning items (eg, “I have feel short of breath 
with only mild exertion (eg climbing a single ﬂ  ight of stairs” 
endorsed by 87%). Participants agreed that even a 5% 
weight loss would result in improved physical functioning, 
and, more importantly, would provide motivation to keep 
losing weight.
In clinical trials of obesity medications and interventions 
which have used the IWQOL-Lite, the largest one-year 
change effect sizes have occurred in the physical function-
ing domain. In contrast, Zhang et al (2007), in a systematic Diabetes, Metabolic Syndrome and Obesity 2008:1 21
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review of interventions on health-related quality of life 
among persons with diabetes, found little effect of antihyper-
glycemic oral agents and/or insulin on physical functioning 
(eg, … climbing several ﬂ  ights of stairs) as measured by the 
Short Form 36 (SF 36) (Ware 2000). Thus while, antihyper-
glycemic agents would not be expected to affect individuals’ 
physical functioning, the results of this study suggest that, if 
indeed, the agents also produced weight loss of 5% to 10% 
in the moderately obese, their effect on physical functioning 
would be positively increased.
Zhang et al (2007) also showed that antihyperglycemic 
medications could have an effect on emotional functioning 
as measured by the SF-36, but results were inconsistent 
across the six studies involving patients with T2DM. In this 
study, participants reported that emotional functioning was 
affected by moderate obesity with self-esteem being the 
emotional component that would most likely be affected by a 
5% to 10% weight loss. The IWQOL-Lite items speciﬁ  cally 
addressing self consciousness and self esteem were endorsed 
as relevant by over 75% of participants. Participants agreed 
that even small amounts of weight loss would improve their 
self-esteem and conﬁ  dence. Thus, emotional functioning in 
terms of self esteem would be important to assess in trials 
evaluating antihyperglycemic medications that produce even 
small amounts of weight loss in those people with T2DM 
and moderate obesity.
Table 3 Response tallies for the impact of weight on quality of life-lite questionnaire
“Because of my weight....” Number reporting this concept as 
relevant
Physical function (n = 30)  %
  I have trouble picking up objects 19 63
  I have trouble tying my shoelaces 22 73
  I have difﬁ  culty getting up from chairs 17 57
  I have trouble using stairs 17 57
  I have difﬁ  culty putting on or taking off my clothes 7 23
  I have trouble with mobility (getting around) 15 50
  I have trouble crossing my legs 10 33
  I feel short of breath with only mild exertion (eg, climbing a single ﬂ  ight of stairs) 26 87
  I am troubled by painful or stiff joints 26 87
  My ankles and lower legs are swollen at the end of the day 8 27
  I am worried about my health 25 83
Self-esteem
  I am self-conscious 24 80
  My self-esteem is not what it could be 23 77
  I feel unsure of myself 13 43
  I don’t like myself 72 3
  I am afraid of being rejected 10 33
  I avoid looking in mirrors or seeing myself in photographs 13 43
  I am embarrassed to be seen in public places 7 23
Sexual life
  I do not enjoy sexual activity 10 33
  I have little or no sexual desire 9 30
  Because of my weight I have difﬁ  culty with sexual performance 8 27
  Because of my weight I avoid sexual encounters whenever possible 10 33
Public distress
  I experience ridicule, teasing, or unwanted attention 5 17
  I worry about ﬁ  tting into seats in public places (eg, theatres, airplanes) 7 23
  I worry about ﬁ  tting through aisles or turnstiles 6 20
  I worry about ﬁ  nding chairs that are strong enough to hold my weight 5 17
  I experience discrimination by others 7 23Diabetes, Metabolic Syndrome and Obesity 2008:1 22
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Social functioning appeared to be affected by the weight 
of only a small number of participants. This again was con-
ﬁ  rmed by the review of the IWQOL-Lite items. Although 
the instrument does not have a social functioning subscale, 
items that imply socialization such as items regarding fear of 
rejection, embarrassment in public, sexuality, experiencing 
ridicule or teasing, discrimination by others were endorsed as 
relevant to them by a third or less participants. Therefore, for 
this population, changes in social functioning are not likely 
to be detected as a result of small weight loss.
With regards to glycemic control, participants acknowl-
edged the importance of glycemic control and the risks of not 
having good glycemic control. Consequently, if required to 
choose between better glycemic control and weight loss, most 
would choose glycemic control. This was especially true for 
those participants who believed that uncontrolled blood sugar 
made it much more difﬁ  cult for them to lose weight. Yet there 
were a smaller number of participants who perceived the 
relationship between obesity and diabetes as one in which the 
weight loss was the priority because they believed the weight 
loss would bring their blood sugar under control. While the 
direction of the relationship may not have been clear, most 
of the participants appeared to acknowledge their obesity as 
a problem as 83% agreed that the IWQOL-Lite item, “I am 
worried about my health,” was relevant to them.
Participants also indicated that role limitations and pain 
would be less with even small amounts of weight loss. As 
reported by participants, the decrease would be directly 
related to the extent to which they were able to experience 
an increase in physical functioning.
After their review, Rubin and Peyrot (1999) concluded 
that compared to people without diabetes, people with 
diabetes had worse quality of life, speciﬁ  cally in the areas 
of physical functioning and well-being. The results of this 
study suggest that some of that decrease in quality of life for 
people with T2DM may be as much a result of their obesity 
as their diabetes. In fact, decreases in physical functioning 
and self-esteem, as well as, increased health distress could 
be directly linked to their obesity and would be the aspects 
of their lives most likely to change with weight loss.
Conclusions
Therapeutic options are continually being improved and 
expanded for patients with T2DM and each has its advan-
tages and disadvantages from the patient perspective. The 
results of this study indicate that therapies which improve 
glycemic control, but also result in weight loss have a clear 
advantage from the patient perspective as long as they do not 
add treatment burden (ie, complexity, hypoglycemia). The 
challenge for the pharmaceutical industry will be to capture 
these advantages using reliable and valid PROs measures. It 
is only then that this advantage can be adequately character-
ized and communicated to patients.
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